Liver disease induced by radioembolization of liver tumors-Reference-Cited by-同舟云学术

Liver disease induced by radioembolization of liver tumors

Published:2008 Issue:7 Volume:112 Page:1538-1546
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Sangro Bruno,Gil-Alzugaray Belen,Rodriguez Javier,Sola Iosu,Martinez-Cuesta Antonio,Viudez Antonio,Chopitea Ana,Iñarrairaegui Mercedes,Arbizu Javier,Bilbao Jose I.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Yttrium-90 Microsphere Therapy for Hepatic Malignancy: Devices, Indications, Technical Considerations, and Potential Complications

2. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres

3. Hepatic arterial90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: Interim safety and survival data on 65 patients

4. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma

Cited by 321 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mapping the landscape of Y90 radioembolisation research: a citation analysis of the top 100 papers;Egyptian Journal of Radiology and Nuclear Medicine;2024-08-28

2. PET/CT-Based Absorbed Dose Maps in⁹⁰Y Selective Internal Radiation Therapy Correlate with Spatial Changes in Liver Function Derived from Dynamic MRI;Journal of Nuclear Medicine;2024-07-03

3. Predictors of Hepatic Decompensation after Yttrium90 Transarterial Radioembolization—Optimizing Patient Selection;Journal of Clinical Interventional Radiology ISVIR;2024-05-13

4. Evaluating therapeutic efficacy of extended shelf-life 90Y glass microspheres in transarterial radioembolization for colorectal cancer: a quantitative FDG PET/CT analysis;Nuclear Medicine Communications;2024-01-12

5. Safety and Efficacy of Selective Internal Radionuclide Therapy with 90Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization;Pharmaceuticals;2024-01-11